Addiction potential of phentermine prescribed during long-term treatment of obesity

Objective:To investigate if phentermine treatment induces phentermine abuse, psychological dependence (addiction) or phentermine drug craving in overweight, obese and weight loss maintenance patients. To investigate whether amphetamine-like withdrawal occurs after abrupt cessation of long-term phent...

Full description

Saved in:
Bibliographic Details
Main Authors: E. J. Hendricks, M. Srisurapanont, S. L. Schmidt, M. Haggard, S. Souter, C. L. Mitchell, D. G. De Marco, M. J. Hendricks, Y. Istratiy, F. L. Greenway
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896690350&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/53763
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-53763
record_format dspace
spelling th-cmuir.6653943832-537632018-09-04T10:00:06Z Addiction potential of phentermine prescribed during long-term treatment of obesity E. J. Hendricks M. Srisurapanont S. L. Schmidt M. Haggard S. Souter C. L. Mitchell D. G. De Marco M. J. Hendricks Y. Istratiy F. L. Greenway Medicine Nursing Objective:To investigate if phentermine treatment induces phentermine abuse, psychological dependence (addiction) or phentermine drug craving in overweight, obese and weight loss maintenance patients. To investigate whether amphetamine-like withdrawal occurs after abrupt cessation of long-term phentermine treatment.Design:Clinical intervention trial with interruption of phentermine treatment in long-term patients.Subjects:269 obese, overweight or formerly obese subjects (age: 20-88 years, BMI: 21-74 kg m -2) treated with phentermine long-term (LTP, N=117), 1.1-21.1 years, or short-term (ATP, N=152), 4-22 days, with phentermine doses of 18.75-112.5 (LTP) and 15-93.75 (ATP) mg per day.Measurements:Module K of the Mini International Neuropsychiatric Interview modified for phentermine (MINI-SUD), Severity of Dependence Scale (SDS), 45-item Cocaine Craving Questionnaire-NOW (CCQ-NOW) modified for phentermine (PCQ-NOW), and Amphetamine Withdrawal Questionnaire (AWQ) modified for phentermine (PWQ).Results:MINI-SUD interviews were negative for phentermine abuse or psychological dependence in all LTP patients. SDS examination scores were low for all LTP and ATP patients, indicating they were not psychologically dependent upon phentermine. PCQ-NOW scores were low for all LTP and ATP patients, indicating neither short-term nor long-term phentermine treatment had induced phentermine craving. Other than an increase in hunger or eating, amphetamine-like withdrawal symptoms did not occur upon abrupt phentermine cessation as measured by sequential PWQ scores.Conclusions:Phentermine abuse or psychological dependence (addiction) does not occur in patients treated with phentermine for obesity. Phentermine treatment does not induce phentermine drug craving, a hallmark sign of addiction. Amphetamine-like withdrawal does not occur upon abrupt treatment cessation even at doses much higher than commonly recommended and after treatment durations of up to 21 years. © 2014 Macmillan Publishers Limited. 2018-09-04T09:57:20Z 2018-09-04T09:57:20Z 2014-02-01 Journal 14765497 03070565 2-s2.0-84896690350 10.1038/ijo.2013.74 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896690350&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/53763
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Medicine
Nursing
spellingShingle Medicine
Nursing
E. J. Hendricks
M. Srisurapanont
S. L. Schmidt
M. Haggard
S. Souter
C. L. Mitchell
D. G. De Marco
M. J. Hendricks
Y. Istratiy
F. L. Greenway
Addiction potential of phentermine prescribed during long-term treatment of obesity
description Objective:To investigate if phentermine treatment induces phentermine abuse, psychological dependence (addiction) or phentermine drug craving in overweight, obese and weight loss maintenance patients. To investigate whether amphetamine-like withdrawal occurs after abrupt cessation of long-term phentermine treatment.Design:Clinical intervention trial with interruption of phentermine treatment in long-term patients.Subjects:269 obese, overweight or formerly obese subjects (age: 20-88 years, BMI: 21-74 kg m -2) treated with phentermine long-term (LTP, N=117), 1.1-21.1 years, or short-term (ATP, N=152), 4-22 days, with phentermine doses of 18.75-112.5 (LTP) and 15-93.75 (ATP) mg per day.Measurements:Module K of the Mini International Neuropsychiatric Interview modified for phentermine (MINI-SUD), Severity of Dependence Scale (SDS), 45-item Cocaine Craving Questionnaire-NOW (CCQ-NOW) modified for phentermine (PCQ-NOW), and Amphetamine Withdrawal Questionnaire (AWQ) modified for phentermine (PWQ).Results:MINI-SUD interviews were negative for phentermine abuse or psychological dependence in all LTP patients. SDS examination scores were low for all LTP and ATP patients, indicating they were not psychologically dependent upon phentermine. PCQ-NOW scores were low for all LTP and ATP patients, indicating neither short-term nor long-term phentermine treatment had induced phentermine craving. Other than an increase in hunger or eating, amphetamine-like withdrawal symptoms did not occur upon abrupt phentermine cessation as measured by sequential PWQ scores.Conclusions:Phentermine abuse or psychological dependence (addiction) does not occur in patients treated with phentermine for obesity. Phentermine treatment does not induce phentermine drug craving, a hallmark sign of addiction. Amphetamine-like withdrawal does not occur upon abrupt treatment cessation even at doses much higher than commonly recommended and after treatment durations of up to 21 years. © 2014 Macmillan Publishers Limited.
format Journal
author E. J. Hendricks
M. Srisurapanont
S. L. Schmidt
M. Haggard
S. Souter
C. L. Mitchell
D. G. De Marco
M. J. Hendricks
Y. Istratiy
F. L. Greenway
author_facet E. J. Hendricks
M. Srisurapanont
S. L. Schmidt
M. Haggard
S. Souter
C. L. Mitchell
D. G. De Marco
M. J. Hendricks
Y. Istratiy
F. L. Greenway
author_sort E. J. Hendricks
title Addiction potential of phentermine prescribed during long-term treatment of obesity
title_short Addiction potential of phentermine prescribed during long-term treatment of obesity
title_full Addiction potential of phentermine prescribed during long-term treatment of obesity
title_fullStr Addiction potential of phentermine prescribed during long-term treatment of obesity
title_full_unstemmed Addiction potential of phentermine prescribed during long-term treatment of obesity
title_sort addiction potential of phentermine prescribed during long-term treatment of obesity
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896690350&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/53763
_version_ 1681424195655827456